| Novel coronavirus (COVID‐19) epidemic: what are the risks for older patients? A Garnier‐Crussard, E Forestier, T Gilbert, P Krolak‐Salmon Journal of the American Geriatrics Society 68 (5), 939, 2020 | 165 | 2020 |
| White matter hyperintensity topography in Alzheimer's disease and links to cognition A Garnier‐Crussard, S Bougacha, M Wirth, S Dautricourt, S Sherif, ... Alzheimer's & Dementia 18 (3), 422-433, 2022 | 112 | 2022 |
| White matter hyperintensities across the adult lifespan: relation to age, Aβ load, and cognition A Garnier-Crussard, S Bougacha, M Wirth, C André, M Delarue, ... Alzheimer's research & therapy 12, 1-11, 2020 | 111 | 2020 |
| White matter hyperintensities in Alzheimer's disease: beyond vascular contribution A Garnier‐Crussard, F Cotton, P Krolak‐Salmon, G Chételat Alzheimer's & Dementia 19 (8), 3738-3748, 2023 | 52 | 2023 |
| Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer’s disease M Gaubert, C Lange, A Garnier-Crussard, T Köbe, S Bougacha, ... Alzheimer's Research & Therapy 13, 1-11, 2021 | 47* | 2021 |
| Role of cardiovascular risk factors on the association between physical activity and brain integrity markers in older adults F Felisatti, J Gonneaud, C Palix, A Garnier-Crussard, F Mézenge, ... Neurology 98 (20), e2023-e2035, 2022 | 18 | 2022 |
| Determinants of medical direct costs of care among patients of a memory center V Dauphinot, A Garnier-Crussard, C Moutet, F Delphin-Combe, HM Späth, ... The Journal of Prevention of Alzheimer's Disease 8 (3), 351-361, 2021 | 15 | 2021 |
| Initial memory deficit profiles in patients with a cerebrospinal fluid Alzheimer's disease signature J Xie, A Gabelle, A Dorey, A Garnier-Crussard, A Perret-Liaudet, ... Journal of Alzheimer’s Disease 41 (4), 1109-1116, 2014 | 15 | 2014 |
| White matter hyperintensities in ageing: pathophysiology, associated cognitive disorders and prevention A Garnier-Crussard, V Desestret, F Cotton, G Chetelat, P Krolak-Salmon La Revue de medecine interne 41 (7), 475-484, 2020 | 14* | 2020 |
| Performance evaluation of automated white matter hyperintensity segmentation algorithms in a multicenter cohort on cognitive impairment and dementia M Gaubert, A Dell’Orco, C Lange, A Garnier-Crussard, I Zimmermann, ... Frontiers in psychiatry 13, 1010273, 2023 | 13 | 2023 |
| Perception of benefits and risks of neurocognitive disorders diagnosis: A French national survey A Garnier-Crussard, J Vernaudon, N Auguste, C Moutet, V Dauphinot, ... Journal of Alzheimer’s Disease 67 (4), 1267-1275, 2019 | 13 | 2019 |
| Vascular health is associated with functional connectivity decline in higher-order networks of older adults M Wirth, M Gaubert, T Köbe, A Garnier-Crussard, C Lange, J Gonneaud, ... Frontiers in integrative neuroscience 16, 847824, 2022 | 7 | 2022 |
| Blunted emotion judgments of body movements in Parkinson’s disease E Bellot, A Garnier-Crussard, E Pongan, F Delphin-Combe, MH Coste, ... Scientific Reports 11 (1), 18575, 2021 | 7 | 2021 |
| Beyond frailty in Alzheimer’s disease: should we move to the concept of intrinsic capacity? A Garnier-Crussard, V Dauphinot, A Zamudio-Rodriguez, ... The Journal of Prevention of Alzheimer's Disease 9 (4), 813-815, 2022 | 5 | 2022 |
| Intrinsic capacity and frailty in older adults with end-stage kidney disease undergoing pre-kidney transplant comprehensive geriatric assessment S Collette-Robert, F Guerville, T Novais, E Pongan, E Morelon, ... The Journal of nutrition, health and aging 28 (6), 100236, 2024 | 4 | 2024 |
| Positive opinion of the French National Authority for Health on the reimbursement of amyloid tracer (Flutemetamol) A Garnier-Crussard, A Flaus European Journal of Nuclear Medicine and Molecular Imaging 50 (2), 253-254, 2023 | 4 | 2023 |
| The identification and diagnosis of delirium in older adults: Which rapid detection tools should we use? B Andorra, A Boussuge, T Gilbert, G Chapelet, T Tannou, ... Gériatrie et Psychologie Neuropsychiatrie du Vieillissement 20 (1), 17-27, 2022 | 4* | 2022 |
| What could be the main levers to promote a timely diagnosis of neurocognitive disorders? A Garnier-Crussard, J Vernaudon, N Auguste, V Dauphinot, ... Journal of Alzheimer's Disease 75 (1), 201-210, 2020 | 4 | 2020 |
| Reliability of the assessment of the clinical dementia rating scale from the analysis of medical records in comparison with the reference method V Dauphinot, S Calvi, C Moutet, J Xie, S Dautricourt, A Batsavanis, ... Alzheimer's Research & Therapy 16 (1), 198, 2024 | 3 | 2024 |
| How to make a shared decision with older persons for end-stage kidney disease treatment: the added value of geronto-nephrology F Guerville, M Pépin, A Garnier-Crussard, JB Beuscart, S Citarda, ... Clinical kidney journal 17 (10), sfae281, 2024 | 2 | 2024 |
Krolak-SalmonHCLAdresse e-mail validée de chu-lyon.fr
